Healthy Aging Health Center
Oldest Elders Surprisingly Spry
Aug. 18, 2008 -- If you make it to your 92nd birthday, your odds of staying spry as you head toward the century mark may be better than you expect.
That news comes from a study of 2,262 Danish adults starting at age 92. Everyone born in 1905 in Denmark and still living there was invited to participate, whether they lived at home or in an institution and needed someone to help them take part in the study. They were followed until they reached 100.
The study was all about seeing whether exceptional longevity came with high levels of disability. The short answer: It didn't. Extreme age didn't bring extreme disability, overall.
The elders did have a slight decline in their ability to perform routine activities, mental skills test scores, grip strength, and other measures, and fewer were independent at 100 than at 92.
"Nonetheless, our finding also suggests that individuals who survive into the highest ages have a health profile that is similar in many aspects to that of individuals who are seven or eight years younger," write the researchers, who included Kaare Christensen, MD, PhD, DMSc, of the Danish Aging Research Center at the University of Southern Denmark.
It's not that no one got sick, slowed down, or died -- only 166 people were still enrolled in the study at age 100. It's more that they didn't linger in what the researchers call a "frail... vegetative state."
"Even though individuals in this age range have an increased risk of disability for each additional year of life, the frailest and most disabled members of the cohort are those who are most likely to die at any given age," explain Christensen and colleagues.
Their bottom line: "Most individuals can expect to experience physical decline before they die, but the postponement of this individual decline makes it possible for us to live into a fourth age" stretching toward 100.
The study appears in this week's online early edition of Proceedings of the National Academy of Sciences.
del.icio.us
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRIPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.
